• Home
  • NEW DAY MEDICINE
  • 4 (78) 2025
  • 228 -4 (78) 2025 - Badritdinova M.N., Pulatova Sh.H. - A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE

228 -4 (78) 2025 - Badritdinova M.N., Pulatova Sh.H. - A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE

A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE

Badritdinova M.N. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Pulatova Sh.H. - Bukhara State Medical Institute named after Abu Ali ibn Sina

Shamsiev K.Y. - Bukhara State Medical Institute named after Abu Ali ibn Sinа, Bukhara branch of the Republican Scientific Research Center of Emergency Medical Care, Uzbekistan

Resume

In patients with complicated ischemic heart disease, myocardial revascularization through coronary artery bypass grafting (CABG) and percutaneous coronary intervention (PCI) is currently regarded as the optimal treatment method [1]. Numerous studies report the outcomes of CABG and PCI as optimal treatment strategies or compare their effectiveness [2]; however, data regarding the causes, conditions, and mechanisms of mortality following these complex procedures remain limited. Objective The aim of this study is to investigate the specific causes of mortality following revascularization and its predictors in patients with complicated coronary artery disease. Materials and Methods Our study is a randomized trial encompassing central and peripheral branches. In each center, anticipated patients with clinical conditions were randomly selected for CABG and PCI procedures based on the clinical judgment and consensus of a cardiac team comprising cardiac surgeons and interventional cardiologists (CABG, n=805; PCI, n=871). Study Results Over a four-year follow-up period after PCI and CABG procedures, 94 and 74 mortality cases were recorded, respectively. The majority of deaths were associated with cardiovascular diseases (52.97%, n=89) [Table 1]. Following PCI, the primary cause of cardiovascular mortality was linked to myocardial infarction (MI) [Figure 1A]. In the CABG group, cardiovascular mortality accounted for 40.54% (n=30), non-cardiovascular mortality for 52.70% (n=39), and in 2.7% of cases (n=2), the cause of death was classified as undetermined [Table 1]. Among cardiovascular deaths, only a few were attributed to vascular causes. The predominant causes of cardiovascular mortality following CABG included chronic heart failure, arrhythmias, and other factors.

Coronary artery bypass grafting, percutaneous coronary intervention, myocardial infarction, chronic heart failure, mortality rate.

First page

1260

Last page

1271

For citation:Badritdinova M.N., Pulatova Sh.H., Shamsiev K.Y. - A METHOD FOR COMPARATIVE ANALYSIS OF THE CAUSES OF MORTALITY AFTER CORONARY ARTERY BYPASS SURGERY AND PERCUTANEOUS CORONARY INTERVENTION IN COMPLICATED CORONARY ARTERY DISEASE//New Day in Medicine 4(78)2025 1260-1271 https://newdayworldmedicine.com/en/new_day_medicine/4-78-2025

List of References

  1. S. Windecker, P. Kolh, F. Alfonso et al. b2014 ESC/EACTS guidelines on myocardial revascularization: the Task Force on Myocardial Revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) Developed with the special contribution of the European Association of Percutaneous Cardiovascular Interventions (EAPCI)., Eur Heart J, 35 (2014), pp. 2541. View in Scopus Google Scholar.
  2. S. Deb, H.C. Wijeysundera, D.T. Ko, H. Tsubota, S. Hill, S.E. Fremes., Coronary artery bypass graft surgery vs percutaneous interventions in coronary revascularization: a systematic review., JAMA, 310 (2013), pp. 2086. View at publisher Crossref View in Scopus Google Scholar.
  3. D.R. Holmes Jr., J.W. Moses, J. Schofer, M.C. Morice, E. Schampaert, M.B. Leon., Cause of death with bare metal and sirolimus-eluting stents., Eur Heart J, 27 (2006), pp. 2815. View at publisher Crossref View in Scopus., Google Scholar.
  4. J. Herlitz, G. Brandrup-Wognsen, K. Caidahl, et al. Cause of death during 13 years after coronary artery bypass grafting with emphasis on cardiac death., Scand Cardiovasc J, 38 (2004), pp. 283-286. View in Scopus, Google Scholar.
  5. D.R. Holmes Jr., K.B. Davis, M.B. Mock, et al. The effect of medical and surgical treatment on subsequent sudden cardiac death in patients with coronary artery disease: a report from the Coronary Artery Surgery Study., Circulation, 73 (1986), pp. 1254. View in Scopus., Google Scholar.
  6. D.R. Holmes Jr., L.J. Kim, M.M. Brooks, et al. The effect of coronary artery bypass grafting on specific causes of long-term mortality in the Bypass Angioplasty Revascularization Investigation., J Thorac Cardiovasc Surg, 134 (2007), pp. 38-4646 e1. View at publisher, Crossref View in Scopus., Google Scholar.
  7. S.J. Head, S. Kaul, M.J. Mack, et al. The rationale for heart team decision-making for patients with stable, complex coronary artery disease. Eur Heart J, 34 (2013), pp. 2510. View at publisher Crossref View in Scopus, Google Scholar.
  8. P.W.Serruys, M.C. Morice, A.P. Kappetein, et al. Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease. N Engl J Med, 360 (2009), pp. 961. View at publisher Crossref Google Scholar.
  9. A.P. Kappetein, T.E. Feldman, M.J. Mack, et al. Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and/or three-vessel disease: 3-year follow-up of the SYNTAX trial., Eur Heart J, 32 (2011), pp. 2125-2134. View at publisher Crossref View in Scopus, Google Scholar.
  10. S.J. Head, D.R. Holmes Jr., M.J. Mack, et al. Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries., J Am Coll Cardiol Intv, 5 (2012), pp. 618-625. View PDF View article View in Scopus Google Scholar.
  11. S.B. King 3rd, S.C. Smith Jr., J.W. Hirshfeld Jr., et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2007 Writing Group to Review New Evidence and Update the ACC/AHA/SCAI 2005 Guideline Update for Percutaneous Coronary Intervention, Writing on Behalf of the 2005 Writing Committee., J Am Coll Cardiol, 51 (2008), pp. 172-209. View PDF View article View in Scopus Google Scholar.
  12. K.A. Eagle, R.A. Guyton, R. Davidoff, et al. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). J Am Coll Cardiol, 44 (2004), pp. 1146-1154. View PDF View article View in Scopus Google Scholar.
  13. D.E. Cutlip, S. Windecker, R. Mehran, et al. Clinical end points in coronary stent trials: a case for standardized definitions., Circulation, 115 (2007), pp. 2344-2351. View in Scopus Google Scholar.
  14. P. Grambsch, T. Therneau. Proportional hazards tests and diagnostics based on weighted residuals Biometrika, 81 (1994), pp. 515-526. View in ScopusGoogle Scholar.
  15. J. Daemen, E. Boersma, M. Flather, et al. Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials., Circulation, 118 (2008), pp. 1146-1154. View in Scopus Google Scholar.
  16. M.A. Hlatky, D.B. Boothroyd, D.M. Bravata, et al. Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials., Lancet, 373 (2009), pp. 1190-1197. View PDF View article View in Scopus Google Scholar.
  17. D.B. Spoon, P.J. Psaltis, M. Singh, et al. Trends in cause of death after percutaneous coronary intervention., Circulation, 129 (2014), pp. 1286-1294. View in Scopus Google Scholar.
  18. P. Carson, J. Wertheimer, A. Miller, et al. The STICH trial (Surgical Treatment for Ischemic Heart Failure): mode-of-death results., J Am Coll Cardiol HF, 1 (2013), pp. 400-408. View PDF View article View in Scopus Google Scholar.
  19. K. Nishiyama, S. Shizuta, T. Doi, et al. Sudden cardiac death after PCI and CABG in the bare-metal stent era: incidence, prevalence, and predictors., Int J Cardiol, 144 (2010), pp. 263-266. View PDF View article View in Scopus Google Scholar.
  20. B.R. Chaitman, R.M. Hardison, D. Adler, et al. The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction., Circulation, 120 (2009), pp. 2529. View in Scopus Google Scholar.

    file

    download